The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
UTC-2 Training for Addiction Treatment Professionals of South Punjab, Pakistan.
“Training of Addiction Professionals for Pakistan Addiction Treatment Practitioners” February 22-25, 2022 (8 am to 6pm) Multan, Islamic Republic of Pakistan Description: Training Name: Training of Addiction Professionals for Pakistan...
Law Enforcement in Prevention Programming
An APSI Prevention Talk on how to appropriately engage law enforcement in the implementation of evidence-based prevention strategies, with specific reference to the prevention of substance use.
Study of SARS-CoV-2 seroprevalence in patients undergoing treatment for addictions in Madrid
Summary Background: Patients with addiction are a vulnerable group in which there is little data on the infection and severity of COVID-19. The objective of this study was to analyze the seroprevalence against SARS-CoV-2 in users in...
HealthCare educational differences in pain management, adverse childhood experiences and their relationship to substance use disorder education
The Ohio Attorney General selected experts from a number of academic fields to the Scientific Committee on Opioid Prevention and Education (SCOPE) to help the State of Ohio in tackling the opioid crisis in the United States. The focus of...
The prevalence of people who inject drugs among those with HIV late presentation: a meta-analysis
Early detection of Acquired Immune Deficiency Syndrome allows infected people to use prophylaxis against opportunistic infections and beginning immediate treatment for secondary complications. People who receive treatment benefit from...
The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya
Cannabis is the most widely used illegal substance in the world, with a global prevalence of 4% among people aged 15 to 64 years and a recent trend of growing use. Cannabis usage can have negative health consequences, such as impaired...
Staff preferences towards electronic data collection from a national take-home naloxone program: a cross-sectional study
In Norway, overdose mortality is over 260 per year, with opioids being implicated in the majority of cases. In 2014, the Norwegian government announced a government-funded nationwide overdose prevention initiative in response to the country...
Barriers to support for people experiencing problem substance use and homelessness: Reading list
The second webinar in our series on homelessness and substances use was presented by Dr Hannah Carver who focused on the different barriers that people experience when trying to access support and the evidence base for different...
An overview of global homelessness and strategies for systemic change
The Institute of Global Homelessness (IGH) drives a global movement to end street homelessness. Their vision is a world where everyone has a home that offers security, safety, autonomy, and opportunity. This paper, published by IGH...
European responses to the needs of people who experience homelessness and use drugs
Summary: This paper explores the evidence base for services designed to meet the needs of people who experience homelessness and use drugs. Through a delimited analysis of existing systematic and rapid evidence reviews, it considers the key...